Relmada Therapeutics, Inc. (RLMD): S-3ASR filed May 13, 2026

Form type

S-3ASR

Filing date

May 13, 2026

Accession number

0001213900-26-055901

Filer

Relmada Therapeutics, Inc. (CIK 1553643)